Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Materials and methods for treatment of hemoglobinopathies

Materials and methods for treatment of hemoglobinopathies

US Patent 12043843 · Granted Jul 23, 2024

Estimated economic value: $729,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Universal donor stem cells and related methods2025
Scarless genome editing through two-step homology directed repair2025
Materials and methods for treatment of pain related disorders2025
Universal donor stem cells and related methods2025
Materials and methods for treatment of hereditary haemochromatosis2025
Materials and methods for treatment of hereditary haemochromatosis2025
Cells lacking B2M surface expression and methods for allogeneic administration o2024
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and use2024
Materials and methods for treatment of hemoglobinopathies2024
Materials and methods for treatment of human genetic diseases including hemoglob2024
Universal donor stem cells and related methods2024
Materials and methods for treatment of Duchenne Muscular Dystrophy2024